Skip to Content
Merck
All Photos(1)

Key Documents

View All Documentation

860502P

Avanti

C2 Ceramide (d18:1/2:0)

Avanti Research™ - A Croda Brand 860502P, powder

Synonym(s):

N-acetoyl-D-erythro-sphingosine

Sign Into View Organizational & Contract Pricing

Select a Size

5 MG
$191.00

$191.00

Estimated to ship on17 April 2025

Request a Bulk Order
All Photos(1)

Select a Size

Change View
5 MG
$191.00

About This Item

Empirical Formula (Hill Notation):
C20H39NO3
CAS Number:
195194-58-2
Molecular Weight:
341.53
MDL number:
MFCD07374281
UNSPSC Code:
12352211
NACRES:
NA.25

$191.00

Estimated to ship on17 April 2025

Request a Bulk Order

form

powder

packaging

pkg of 1 × 5 mg (860502P-5mg)

manufacturer/tradename

Avanti Research™ - A Croda Brand 860502P

lipid type

sphingolipids

shipped in

dry ice

storage temp.

−20°C

SMILES string

OC[C@]([H])(NC(C)=O)[C@]([H])(O)/C=C/CCCCCCCCCCCCC

InChI

1S/C20H39NO3/c1-3-4-5-6-7-8-9-10-11-12-13-14-15-16-20(24)19(17-22)21-18(2)23/h15-16,19-20,22,24H,3-14,17H2,1-2H3,(H,21,23)/b16-15+/t19-,20+/m0/s1

InChI key

BLTCBVOJNNKFKC-QUDYQQOWSA-N

General description

C2 Ceramide (d18:1/2:0) is a short-chain ceramide. In general ceramides are synthesized by de novo pathway from palmitic acid via series of intermediates to ceramidein the presence of dihydroceramide Δ4-desaturase.[1]

Application

C2 Ceramide (d18:1/2:0) has been used to treat protoplasts for reactive oxygen species generation[2] and as an substrate for sphingomyelin synthase 2 enzyme.[3] It is suitable for use as an exogenous supplement in hippocampal cell cultures for the production of 2-hydroxyeicosatetraenoic acid (12-(S)-HETE).[4]

Biochem/physiol Actions

C2 ceramide inhibits the progression of human bronchocarcinoma by modulating the matrix metallopeptidases-2 levels. It also inhibits glioma invasion[5] and induces apoptosis in HT-29 and HCT-116 human colon cancer cells.[6] Treatment of myotubes with C2-ceramide leads to decrease in glucose uptake and glycogen synthesis.[1] C2 along with C6 ceramides induces insulin resistance in myoblastic C2C12 cell line and L6 myotubes.[7]

Packaging

5 mL Amber Glass Screw Cap Vial (860502P-5mg)

Legal Information

Avanti Research is a trademark of Avanti Polar Lipids, LLC

Storage Class Code

11 - Combustible Solids

WGK

WGK 3

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documents section.

If you need assistance, please contact Customer Support.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Ceramide elevates 12-hydroxyeicosatetraenoic acid levels and upregulates 12-lipoxygenase in rat primary hippocampal cell cultures containing predominantly astrocytes
Prasad VVTS, et al.
Neurochemistry International, 53(6-8), 220-229 (2008)
Induction of apoptosis by sphingosine, sphinganine, and C2-ceramide in human colon cancer cells, but not by C2-dihydroceramide
Ahn EH and Schroeder JJ
Anticancer research, 30(7), 2881-2884 (2010)
Exogenous C2 ceramide suppresses matrix metalloproteinase gene expression by inhibiting ROS production and MAPK signaling pathways in PMA-stimulated human astroglioma cells
Jung JS, et al.
International Journal of Molecular Sciences, 17(4), 477-477 (2016)
Sphingolipid Metabolism: New Insight into Ceramide-Induced Lipotoxicity in Muscle Cells
Bandet C, et al.
International Journal of Molecular Sciences, 20(3), 479-479 (2019)
Ceramide and insulin resistance: how should the issue be approached?
Gorski J
Diabetes, 61(12), 3081-3083 (2012)
View All Related Papers

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service